Indaptus Therapeutics Announces Opening of Next Cohort in Single Dose Ranging Study of Decoy20
August 10, 2023 08:45 ET
|
Indaptus Therapeutics
Cohort 1 patients exhibited a significant immune response consistent with the mechanism of actionSafety Review Committee approved continuation to the next cohort of patients NEW YORK, Aug. 10,...